MTOR downregulates iodide uptake in thyrocytes

Journal of Endocrinology

Volumn 206, Issue 1, 2010, Pages 113-120

  De Souza, Elaine Cristina Lima ^a   Padrón, Álvaro Souto ^a   Braga, William Miranda Oliveira ^a   De Andrade, Bruno Moulin ^a   Vaisman, Mário ^a   Nasciutti, Luiz Eurico ^a   Ferreira, Andrea Claudia Freitas ^a   De Carvalho, Denise Pires ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; EVEROLIMUS; INSULIN; IODIDE; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN P70; PROTEIN S6; RAPAMYCIN; SODIUM IODIDE SYMPORTER; THYROTROPIN;

ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; IN VIVO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL LINE; CELL SURVIVAL; CHROMONES; INSULIN; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; IODINE RADIOISOTOPES; MORPHOLINES; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIROLIMUS; SODIUM IODIDE; SYMPORTERS; THYROID GLAND; THYROTROPIN;

EID: 77953857289     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1677/JOE-09-0436     Document Type: Article

References (35)

1. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P & Hemmings BA 1996 Mechanisms of activation of protein kinase B by insulin and IGF-1. EMBO Journal 15 6541-6551. (Pubitemid 26413787)
2. Bellacosa A, Kumar CC, Di Cristofano A & Testa JR 2005 Activation of Akt kinases in cancer: implications for therapeutical targeting. Advances in Cancer Research 94 29-86.
3. Brewer C, Yeager N & Di Cristofano A 2007 Thyroid-stimulating hormone-initiated proliferative signals converge in vivo on the mTOR kinase without activating Akt. Cancer Research 67 8002-8006.
4. Cass LA, Summers SA, Prendergast GV, Backer JM, Birnbaum MJ & Meinkoth JL 1999 Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulated proliferation. Molecular Cell Biology 19 5882-5891.
5. Coulonval K, Vandeput F, Stein RC, Kozma SC, Lamy F & Dumont JE 2000 Phosphatidylinositol 3-kinase, protein kinase B and ribosomal S6 kinases in the stimulation of thyroid epithelial cell proliferation by cAMP and growth factors in the presence of insulin. Biochemical Journal 348 351-358.
6. Dai G, Levy O & Carrasco N 1996 Cloning and characterization of the thyroid iodide transporter. Nature 379 458-460.
7. Dohan O, De la Vieja A, Paroder V, Riedel C, Artani M, Reed M, Ginter CS & Carrasco N 2003 The sodium/iodide symporter (NIS): characterization, regulation, and medical significance. Endocrine Reviews 24 48-77.
8. Ferreira AC, Lima LP, Araújo RL, Muller G, Rocha RP, Rosenthal D & Carvalho DP 2005 Rapid regulation of thyroid sodium-iodide symporter activity by thyrotropin and iodine. Journal of Endocrinology 184 69-76.
9. Garcia B & Santisteban P 2002 PI3K is involved in the IGF-1 inhibition of TSH-induced sodium/iodide symporter gene expression. Journal of Endocrinology 16 342-352.
10. Guertin DA & Sabatini DM 2005 An expanding role for mTOR in cancer. Trends in Molecular Medicine 11 353-361.
11. Hresko RC & Mueckler M 2005 mTOR.RICTOR is the Ser 473 kinase for Akt/protein kinase B in 3T3-L1 adipocytes. Journal of Biological Chemistry 280 40406-40416.
12. Inoki K, Li Y, Zhu T, Wu J & Guan KL 2002 TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signaling. Nature Cell Biology 4 648-657.
13. Jacinto E, Loewith R, Schmidt A, Lin S, Ruegg MA, Hall A & Hall MN2004 Mammaliam TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nature Cell Biology 6 1122-1128.
14. Kimura T, Van Keymeulen A, Golstein J, Fusco A, Dumont JE & Roger PP 2001 Regulation of thyroid cell proliferation by TSH and other factors: a critical evaluation of in vitro models. Endocrine Reviews 22 631-656.
15. Kogai T, Sajid-Crockett S, Newmarch LS, Liu YY & Brent GA 2008 Phosphoinositide-3-kinase (PI3K) inhibition induces sodium/iodide symporter expression (NIS) in rat thyroid cells and human pappilary cancer cells. Journal of Endocrinology 199 243-252.
16. Laglia G, Zeiger MA, Leipricht A, Caturegli P, Levine MA, Kohn LD & Saji M 1996 Increased cyclic adenosine 3′,5′-monophosphate inhibits G protein-coupled activation of phospholipase C in rat FRTL-5 thyroid cells. Endocrinology 137 3170-3176.
17. Liu D, Hou P, Liu Z, Wu G & Xing M 2009 Genetic alterations in the phosphoinositide 3-kinase/Akt signaling pathway confer sensitivity of thyroid cancer cells to therapeutic targeting of Akt and mammalian target of rapamycin. Cancer Research 69 7311-7319.
18. Manning BD, Tee AR, Longsdon MN, Blenis J & Cantley LC 2002 Identification of the tuberous slerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase/Akt pathway. Molecular Cell 10 151-162.
19. Mazaferri EL 2000 Carcinoma of the follicular epithelium. In Thyroid: a Fundamental and Clinical Text. edn 8, pp 904-930. Eds L Braverman & RUtiger. New York: Lippincott Williams & Wilkins.
20. Medina DL, Toro MJ & Santisteban P 2000 Somatostatin interferes with thyrotropin-induced G1-S transition mediated by cAMP-dependent protein kinase and phosphatidylinositol 3-kinase. Involvement of RhoA and cyclin E cyclin dependent kinase 2 complexes. Journal of Biological Chemistry 275 15549-15556.
21. Navé BT, Ouwens M, Withers DJ, Alessi DR & Shepherd PR 1999 Mammalian target of rapamycin is a direct target for protein kinase B: identification of a convergence point for opposing effects of insulin and amino-acid deficiency on protein translation. Biochemical Journal 344 421-431.
22. Papewalis C, Wuttke M, Schinner S, Willenberg HS, Baran AM, Scherbaum WA & Schott M 2009 Role of the novel mTOR inhibitor RAD001 (everolimus) in anaplastic thyroid cancer. Hormone and Metabolic Research 41 752-756.
23. Riedel C, Levy O & Carrasco N 2001 Post-transcriptional regulation of the sodium/iodide symporter by thyrotropin. Journal of Biological Chemistry 276 21458-21463.
24. Roger PP, Servais P & Dumont JE 1987 Induction of DNA synthesis in dog thyrocytes in primary culture: synergistic effects of thyrotropin and cyclic AMP with epidermal growth factor and insulin. Journal of Cellular Physiology 130 58-67.
25. Sarbassov DD, Ali SM, Kim DH, Quertin DA, Latek RR, Erdjument- Bromage H, Tempst P & Sabatini DM 2004 Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoesqueleton. Current Biology 14 1296-1302.
26. Sarbassov DD, Ali SM & Sabatini DM 2005a Growing roles for the mTOR pathway. Current Opinion in Cell Biology 17 596-603.
27. Sarbassov DD, Quertin DA, Ali SM & Sabatini DM 2005b Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex. Science 307 1098-1101.
28. Sarbassov DD, Ali SM, Sengupta S, Sheen JH, Hsu PP, Bagley AF, Markhard AL & Sabatini DM 2006 Prolonged rapamycin treatment inhibits mTORC2 assembly and Akt/PKB. Molecular Cell 22 159-168.
29. Suh JM, Song JH, Kim DH, Kim H, Chung HK, Hwang JH, Kim JM, Hwang ES, Chung J, Han JH et al. 2003 Regulation of the phosphatidylinositol 3-kinase, Akt/protein kinase B, FRAP/mammalian target of rapamycin, and ribosomal S6 kinase 1 signaling pathways by thyroid-stimulating hormone (TSH) and stimulating type TSH receptor antibodies in the thyroid gland. Journal of Biological Chemistry 278 21960-21971.
30. Unterholzner S, Willhauck MJ, Cengic N, Schü tz M, Göke B, Morris JC & Spitzweg C 2006 Dexamethasone stimulation of retinoic acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells. Journal of Clinical Endocrinology and Metabolism 91 69-78.
31. Vassart G & Dumont JE 1992 The thyrotropin receptor and the regulation of thyrocyte function and growth. Endocrine Reviews 13 596-611.
32. - symporter gene methylation status. Journal of Clinical Endocrinology and Metabolism 84 2449-2457.
33. Weiss SJ, Philp NJ, Ambesi-Impiobato FS & Grollman EF 1984 Thyrotropin stimulated iodide transport mediated by adenosine 3′,5′-monophosphate and dependent on protein synthesis. Endocrinology 114 1099-1107.
34. Yeager N, Brewer C, Cai KQ, Xu XX & Di Cristofano A 2008 Mammalian target of rapamycin is the key effector of phosphatidyliositol-3- OH-initiated proliferative signals in the thyroid follicular epithelium. Cancer Research 68 444-449.
35. Zaballos MA, Garcia B & Santisteban P 2008 Gβγ dimers released in response to thyrotropin activate phosphoinositide 3-kinase and regulate gene expression in thyroid cells. Molecular Endocrinology 22 1183-1199.